# InvestorNewsBreaks – Branded Legacy, Inc. (OTC: BLEG) Advances Engineering of Air-Driven Intranasal Drug Delivery Mold

Branded Legacy (OTC: BLEG), a leader in innovative addiction treatment and harm reduction solutions, announced that its subsidiary, BioLegacy Evaluative Group Inc., has begun engineering and development of a unitary device mold for its proprietary air-driven intranasal drug delivery platform. The milestone advances scalable production of its single-use device for rapid, reliable therapeutic delivery, including its flagship inhaled naloxone program. Building on a September 2025 provisional patent filing and the opening of a GMP-compliant facility in Vancouver, the development strengthens Branded Legacy’s capacity to address the opioid crisis through affordable, high-quality pharmaceutical solutions.

 To view the full press release, visit https://ibn.fm/Lgrhz

 About Branded Legacy, Inc.Branded Legacy, Inc. (OTC: BLEG) is a forward-thinking holdings company dedicated to pioneering solutions in addiction treatment and harm reduction. Through its subsidiary, BioLegacy Evaluative Group, and strategic collaborations with leading institutions like McMaster University and Stanford University, the company drives transformative research and innovation. With a state-of-the-art GMP manufacturing facility in Vancouver, Branded Legacy leverages advanced production capabilities to deliver cutting-edge products, positioning itself as a leader in addressing critical public health challenges.

 For more information, visit the company’s website at https://BrandedLegacy.com.

 About InvestorWire

 InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

 For more information, please visit https://www.InvestorWire.com

 Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

 InvestorWireAustin, Texaswww.InvestorWire.com512.354.7000 OfficeEditor@InvestorWire.com

 InvestorWire is powered by IBN 

---

[Original/Source Press Release](https://rss.investorbrandnetwork.com/iw/investornewsbreaks-branded-legacy-inc-otc-bleg-advances-engineering-of-air-driven-intranasal-drug-delivery-mold/)
                    

[Newsramp.com TLDR](https://newsramp.com/curated-news/branded-legacy-advances-revolutionary-intranasal-drug-delivery-platform/0dc990bc6927c712ce6dff2ecaf29b8a) 

 

 



![Blockchain Registration](https://cdn.newsramp.app/ibn/qrcode/2510/27/healjtuV.webp)